Results 1 to 10 of about 2,979,111 (255)

Prospects for Expanding Drug Therapy for Multiple Drug Resistant and Extensively Drug Resistant Tuberculosis

Туберкулез и болезни лёгких, 2022
This review analyzes 64 publications on repurposed antibiotics and the prospects of their use in the treatment of multiple drug resistant and extensively drug resistant tuberculosis.
G. N. Mozhokina, A. G. Samoylov, I. А. Vasilyeva   +2 more
doaj   +2 more sources

Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial [PDF]

Nature Communications
Drug-resistant tuberculosis remains a major global health challenge, and excessive inflammation may contribute to tissue damage and poor outcomes. We conducted a phase IIA prospective open-label pilot trial (ClinicalTrials.gov: NCT02781909) evaluating ...
Kaori L. Fonseca, Judith Farrés, Ketevan Barbakadze, Iza Jikia, Malkhaz Tsotskhalashvili, Juan M. García-Illarramendi, Lilibeth Arias, Kennedy Otwombe, Chiara Sopegno, Albert Despuig, Neil Martinson, Nadiia Buhiichyk, Tamta Korinteli, Émilie Layre, Jérôme Nigou, Zaza Avaliani, Nestani Tukvadze, Sergo Vashakidze, Cristina Vilaplana   +18 more
doaj   +2 more sources

Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France [PDF]

Emerging Infectious Diseases
We report occupational transmission of extensively drug-resistant tuberculosis (TB) to a healthcare worker in France receiving tumor necrosis factor α inhibitor therapy. Despite airborne precautions, the healthcare worker contracted TB working in a high-
Corentin Poignon, Frédéric Vandenbos, Karine Risso, Delphine Viard, Esther Gydé, Alice Gaudart, David Chirio, Nicolas Veziris, Michel Carles   +8 more
doaj   +2 more sources

Extensively Drug-Resistant Neisseria gonorrhoeae Strain, Canada [PDF]

Emerging Infectious Diseases
We identified a case of extensively drug-resistant (ceftriaxone- and cefixime-resistant and high-level azithromycin-resistant) Neisseria gonorrhoeae in Canada.
Brigitte Lefebvre, Irene Martin, Robyn Thorington, Julian Gitelman, Andrew Bui-Nguyen, Claude Fortin, Judith Fafard   +6 more
doaj   +2 more sources

Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis

International Journal of Infectious Diseases, 2023
Objectives: To estimate the pooled proportion of extensively drug-resistant tuberculosis (XDR-TB) and pre-extensively drug-resistant tuberculosis (pre-XDR-TB) in patients with multidrug-resistant TB (MDR-TB).
Getu Diriba, Ayinalem Alemu, Bazezew Yenew, Habteyes Hailu Tola, Dinka Fikadu Gamtesa, Hilina Mollalign, Kirubel Eshetu, Shewki Moga, Saro Abdella, Getachew Tollera, Abebaw Kebede, Mesay Hailu Dangisso   +11 more
doaj   +1 more source

Upcoming Multi-drug-Resistant and Extensively Drug-Resistant Bacteria [PDF]

Research in Molecular Medicine, 2022
Multi-drug-resistant (MDR) and extensively drug-resistant (XDR) bacteria are becoming a serious global health issue, which may soon become untreatable by clinicians.
Ciamak Ghazaei
doaj  

Extensively drug-resistant Alcaligenes faecalis infection

BMC Infectious Diseases, 2020
Background Alcaligenes faecalis is usually causes opportunistic infections in humans. Alcaligenes faecalis infection is often difficult to treat due to its increased resistance to several antibiotics.
Chienhsiu Huang
doaj   +1 more source

EXTENSIVELY DRUG RESISTANT TUBERCULOSIS (XDR TB)

Averrous: Jurnal Kedokteran dan Kesehatan Malikussaleh, 2019
Tuberkulosis adalah penyakit infeksi kronis menular yang masih merupakan masalah kesehatan masyarakat di dunia termasuk Indonesia. Tuberkulosis (TB) sebagian besar akan mengalami penyembuhan dengan pengobatan.
Sarah Rahmayani Siregar
doaj   +1 more source

Efficacy and Safety of Colistin versus Tigecycline for Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens—A Meta-Analysis

Antibiotics, 2022
Background: We intended to compare the efficacy and safety outcomes of colistin versus tigecycline as monotherapy or combination therapy against multi-drug resistant (MDR) and extensively drug-resistant (XDR) pathogens. Methods: A search was conducted in
Dina Abushanab, Ziad G. Nasr, Daoud Al-Badriyeh   +2 more
doaj   +1 more source

Bacteriophages in Infectious Diseases and Beyond—A Narrative Review

Antibiotics, 2023
The discovery of antibiotics has revolutionized medicine and has changed medical practice, enabling successful fighting of infection. However, quickly after the start of the antibiotic era, therapeutics for infectious diseases started having limitations ...
Petros Ioannou, Stella Baliou, George Samonis   +2 more
doaj   +1 more source